Open Access
Numéro |
Med Sci (Paris)
Volume 40, Numéro 1, Janvier 2024
La cavité orale et les dents au cœur de la santé
|
|
---|---|---|
Page(s) | 49 - 56 | |
Section | M/S Revues | |
DOI | ||
Publié en ligne | 1 février 2024 |
- Suárez LJ, Garzón H, Arboleda S et al. Oral Dysbiosis and Autoimmunity: From Local Periodontal Responses to an Imbalanced Systemic Immunity. A Review. Front Immunol 2020; 11 : 591255.
- Wang L, Wang F-S, Gershwin ME. Human autoimmune diseases: A comprehensive update. J Intern Med 2015 ; 278 : 369–395.
- Ruff WE, Greiling TM, Kriegel MA. Host-microbiota interactions in immune-mediated diseases. Nat Rev Microbiol 2020; 18 : 521–38.
- Claessens YE, Mouthon L. Maladies rares en médecine d’urgence: définition et classification des maladies auto-immunes. Références en médecine d’urgence. Collection de la SFMU 2013, Chap 1 : 1–12.
- Saccucci M, Di Carlo G, Bossù Met al. Autoimmune diseases and their manifestations on oral cavity : Diagnosis and clinical management. J Immunol Res 2018 ; 2018 : 6061825.
- Vaillant L, Chauchaix-Barthès S, Hüttenberger B, et al. Le syndrome « gingivite érosive chronique » : Étude rétrospective de 33 cas. Annales de dermatologie et de vénéréologie 2000; 127 : 381–7.
- Bach JF. Revisiting the Hygiene Hypothesis in the Context of Autoimmunity. Front Immunol 2021; 11 : 615192.
- De Luca F, Shoenfeld Y. The microbiome in autoimmune diseases. Clin Exp Immunol 2019 ; 195 : 74–85.
- Harrington LE, Hatton RD, Mangan PRet al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005 ; 6 : 1123–1132.
- Ortiz Wilczyñski JM, Olexen CM, Errasti AE, et al. GAS6 signaling tempers Th17 development in patients with multiple sclerosis and helminth infection. PLoS Pathog 2020; 16 : e1009176.
- Dutzan N, Kajikawa T, Abusleme L, et al. A dysbiotic microbiome triggers TH17 cells to mediate oral mucosal immunopathology in mice and humans. Sci Transl Med 2018; 10 : eaat0797.
- Yokota SI, Hirata D, Minota Set al. Autoantibodies against chaperonin CCT in human sera with rheumatic autoimmune diseases: comparison with antibodies against other Hsp60 family proteins. Cell Stress Chaperones 2000 ; 5 : 337–346.
- Miller WB. The Eukaryotic Microbiome: Origins and Implications for Fetal and Neonatal Life. Front Pediat 2016 ; 4 : 96.
- Kobayashi R, Ogawa Y, Hashizume-Takizawa T, et al. Oral bacteria affect the gut microbiome and intestinal immunity. Pathog Dis 2020; 78 : ftaa024.
- Atarashi K, Suda W, Luo C, Kawaguchi T, et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science 2017 ; 358 : 359–365.
- Giordano-Kelhoffer B, Lorca C, March Llanes J, et al. Oral Microbiota, Its Equilibrium and Implications in the Pathophysiology of Human Diseases: A Systematic Review. Biomedicines 2022; 10 : 1803.
- Siddiqui H, Chen T, Aliko Aet al. Microbiological and bioinformatics analysis of primary Sjogren’s syndrome patients with normal salivation. J Oral Microbiol 2016 ; 8 : 31119.
- Otsuka K, Sato M, Tsunematsu T, et al. Virus Infections Play Crucial Roles in the Pathogenesis of Sjögren’s Syndrome. Viruses 2022; 14 : 1474.
- Masuko K. Will the COVID-19 pandemic trigger future occurrence of autoimmunity like Sjögren’s syndrome?. Int J Rheum Dis 2021; 24 : 963–5.
- Krutyholowa A, Strzelec K, Dziedzic A, et al. Host and bacterial factors linking periodontitis and rheumatoid arthritis. Front Immunol 2022; 13 : 980805.
- Laugisch O, Wong A, Sroka Aet al. Citrullination in the periodontium—A possible link between periodontitis and rheumatoid arthritis. Clin Oral invest 2016 ; 20 : 675–683.
- Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol 2021; 21 : 426–40.
- De Pablo P, Chapple IL, Buckley CDet al. Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol 2009 ; 5 : 218–224.
- Potempa J, Mydel P, Koziel J. The case for periodontitis in the pathogenesis of rheumatoid arthritis. Nat Rev Rheumatol 2017 ; 13 : 606–620.
- Maresz KJ, Hellvard A, Sroka Aet al. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog 2013 ; 9 : e1003627.
- Gully N, Bright R, Marino Vet al. Porphyromonas gingivalis peptidylarginine deiminase, a key contributor in the pathogenesis of experimental periodontal disease and experimental arthritis. PLoS One 2014 ; 9 : e100838.
- Konig MF, Abusleme L, Reinholdt J, et al. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med 2016; 8 : 369ra176.
- Martinez-Martinez RE, Abud-Mendoza C, Patiño-Marin N, et al. Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J Clin Periodontol 2009 ; 36 : 1004–1010.
- Payne JB, Golub L. M Thiele GM, et al. The link between periodontitis and rheumatoid arthritis : A periodontist’s perspective. Curr Oral health Rep 2015 ; 2 : 20–29.
- Golub LM PB, Reinhart RA, et al. Can systemic diseases co-induce (not just exacerbate) periodontitis? A hypothetical “two-hit” model. J Dental Res 2006 ; 85 : 102–105.
- Mays JW, Sarmadi M, Moutsopoulos NM. Oral Manifestations of Systemic Autoimmune and Inflammatory Diseases : Diagnosis and Clinical Management. J Evid Based Dent Pract 2012 ; 12 : 265–282.
- Benli M, Batool F, Stutz C, et al. Orofacial manifestations and dental management of systemic lupus erythematosus : A review. Oral Dis 2021; 27 : 151–67.
- Negrini S, Emmi G, Greco M, et al. Sjögren’s syndrome : A systemic autoimmune disease. Clin Exp Med 2022; 22 : 9–25.
- Benz K, Baulig C, Knippschild S, et al. Prevalence of Oral and Maxillofacial Disorders in Patients with Systemic Scleroderma-A Systematic Review. Int J Environ Res Public Health 2021; 18 : 5238.
- Siar CH, Yeo KB, Nakano Ket al. Strawberry gingivitis as the first presenting sign of Wegener’s granulomatosis: report of a case. Eur J Med Res 2011 ; 16 : 331–334.
- Zhu F, Ang JY. 2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease. Curr Infect Dis Rep 2021; 23 : 3.
- Bouaziz A., Le Scanff J., Chapelon-Abric C, et al. Oral involvement in sarcoidosis : Report of 12 cases. QJM 2012; 105 : 755–67.
- Ramos-e-Silva M., Ferreira A, De-Moura-Castro JC.. Oral involvement in autoimmune bullous diseases. Clin Dermatol 2011 ; 29 : 443–454.
- Sahin T, Brygo A, Delaporte Eet al. Les manifestations orales de la maladie de Crohn. Swiss Dent J 2017 ; 127 : 644–653.
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.